MedPath

A study comparing the effects of two different doses of intravenous Dexmedetomidine (0.5 mcg/kg and 1 mcg/kg) on changes in heart rate and blood pressure during removal of endotracheal tube in abdominal surgeries.

Phase 2
Conditions
Health Condition 1: O- Medical and Surgical
Registration Number
CTRI/2024/04/065697
Lead Sponsor
Dr Shubhra Paul
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

1.18 -45 years in both sex.

2.ASA grade I and II

3.Elective Abdominal Surgeries

Exclusion Criteria

1.Active upper respiratory tract infections.

2.Known case of drug allergy.

3 Patients with respiratory dysfunction and obstructive sleep apnea.

4.Patients who are obese.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
To determine whether Dexmedetomidine 0.5 microgram per kilogram body weight or Dexmedetomidine 1 microgram per kilogram body weight is more effective in attenuating haemodynamic responses like heart rate, mean arterial pressure,systolic blood pressure and diastolic blood pressure during extubation in abdominal surgeries.Timepoint: Outcomes mentioned above will be measured at 0 mins, 1 min, 3 mins, 5 mins, 10 mins, 15 mins, 20 mins, 25 mins and 30 mins.
Secondary Outcome Measures
NameTimeMethod
To compare the effects of Dexmedetomidine 0.5 mcg/kg ,1 mcg/kg and placebo on extubation quality score.Timepoint: To assess the extubation quality score between all the groups from extubation to every 5 mins up to 30 mins after extubation.
© Copyright 2025. All Rights Reserved by MedPath